Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

Lexeo Therapeutics has posted updated data in Friedreich ataxia (FA) patients, linking a gene therapy to improvements on ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...

As scientists across the U.S. face increasing uncertainty due to funding freezes and mass layoffs at health agencies, German ...

J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...

| Facing “build versus buy,” or “rent versus own” for integration? Get a guide to the considerations for your organization’s ...

Just after PureTech Health confirmed it was in talks with Nordic Capital regarding a possible buyout, Nordic quickly set the record straight with its own announcement that it does not intend to mak | ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South Korean company’s tech to bypass the blood-brain barrier. | GSK has continued ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

The cuts impact more than $2.4 billion in grant money, including $1.3 billion in grant funds already spent on projects ...